Manage skin toxicities associated with EGFR inhibitors.
Elisa
E
Becze
D003875:Drug Eruptions / Q000209:etiology / Q000451:nursing / Q000517:prevention & control*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D017410:Practice Guidelines as Topic; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*
D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors